Drug Shortage Report for APO-ELETRIPTAN

Last updated on 2021-09-15 History
Report ID 123558
Drug Identification Number 02386062
Brand name APO-ELETRIPTAN
Common or Proper name ELETRIPTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-31
Estimated end date 2021-09-24
Actual end date
Shortage status Actual shortage
Updated date 2021-09-15
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-09-15 French Compare
v14 2021-09-15 English Compare
v13 2021-07-29 French Compare
v12 2021-07-29 English Compare
v11 2021-07-29 English Compare
v10 2021-05-07 French Compare
v9 2021-05-07 English Compare
v8 2020-12-11 French Compare
v7 2020-12-11 English Compare
v6 2020-11-06 French Compare
v5 2020-11-06 English Compare
v4 2020-10-23 French Compare
v3 2020-10-23 English Compare
v2 2020-09-02 French Compare
v1 2020-09-02 English Compare